SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008120
Filing Date
2023-05-04
Accepted
2023-05-04 16:23:29
Documents
102
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20230331x10q.htm   iXBRL 10-Q 2394245
2 EX-10.1 bpmc-20230331xex10d1.htm EX-10.1 104211
3 EX-31.1 bpmc-20230331xex31d1.htm EX-31.1 11332
4 EX-31.2 bpmc-20230331xex31d2.htm EX-31.2 11403
5 EX-32.1 bpmc-20230331xex32d1.htm EX-32.1 10650
  Complete submission text file 0001558370-23-008120.txt   9804167

Data Files

Seq Description Document Type Size
6 EX-101.SCH bpmc-20230331.xsd EX-101.SCH 82729
7 EX-101.CAL bpmc-20230331_cal.xml EX-101.CAL 68900
8 EX-101.DEF bpmc-20230331_def.xml EX-101.DEF 319536
9 EX-101.LAB bpmc-20230331_lab.xml EX-101.LAB 612208
10 EX-101.PRE bpmc-20230331_pre.xml EX-101.PRE 537241
96 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20230331x10q_htm.xml XML 1626425
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 23889146
SIC: 2834 Pharmaceutical Preparations